VYNE
VYNE THERAPEUTICS INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $1.63 | $0.68 | -59% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $1.73 | $0.68 | -61% |
| Two Sigma Investments | Q4 2025(8Q snapshot) | 2Q | $0.37 | $0.68 | +81% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at VYNE Therapeutics Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 2, 2026 — the most recent Form 4 on file — not from today.
- Form 40001727794-26-000006Jun 2, 2026
- Form 40001867033-26-000004Apr 2, 2026
- Form 40001727756-26-000004Apr 2, 2026
- Form 40001727809-26-000004Apr 2, 2026
- Form 40001727794-26-000004Apr 2, 2026
- Form 40001727794-26-000002Jan 5, 2026
- Form 40001867033-26-000002Jan 5, 2026
- Form 40001727756-26-000002Jan 5, 2026
- Form 40001727809-26-000002Jan 5, 2026
- Form 40001632295-25-000005Dec 15, 2025
- Form 40001055404-25-000004Dec 15, 2025
- Form 40001417397-25-000004Dec 15, 2025
- Form 40001240499-25-000004Dec 15, 2025
- Form 40001867033-25-000003Oct 2, 2025
- Form 40001727756-25-000003Oct 2, 2025
Fundamentals
XBRL · VYNE THERAPEUTICS INC.Annual figures sourced directly from VYNE THERAPEUTICS INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for VYNE Therapeutics Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- S-4/ARegistration (M&A, amended)Jun 3, 2026
- 8-KFORM 8-KMay 21, 2026
- 10-QQuarterly reportMay 15, 2026
- S-4/ARegistration (M&A, amended)Apr 28, 2026
- S-4Registration (M&A)Mar 31, 2026
- 8-KFORM 8-KMar 11, 2026
- 10-KAnnual reportFeb 27, 2026
- 8-KFORM 8-KJan 30, 2026
- 8-KFORM 8-KDec 17, 2025
- 8-KFORM 8-KDec 12, 2025
- DEF 14AProxy statementNov 12, 2025
- 10-QQuarterly reportNov 6, 2025
- 8-KMaterial eventNov 6, 2025
- 8-KFORM 8-KSep 12, 2025
- 10-QQuarterly reportAug 14, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | open | $0.67 | $0.68 | +1% |
| Citadel Advisors | Q1 2026 | open | $0.59 | $0.68 | +14% |
| Two Sigma Investments | Q4 2025 | open | $0.37 | $0.68 | +81% |
| Citadel Advisors | Q3 2024 | Q4 2025 | $1.73 | $0.37 | -78% |
| Renaissance Technologies | Q3 2024 | Q4 2025 | $1.63 | $0.37 | -77% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.